A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
HIV Infection
Interventions
DRUG

ritonavir

ritonavir oral capsules or oral solution

DRUG

fosamprenavir

fosamprenavir oral suspension or tablet

Trial Locations (42)

1150

GSK Investigational Site, Lisbon

2700

GSK Investigational Site, Amadora

10016

GSK Investigational Site, New York

10021

GSK Investigational Site, New York

10457

GSK Investigational Site, The Bronx

16132

GSK Investigational Site, Genoa

20122

GSK Investigational Site, Milan

20142

GSK Investigational Site, Milan

23298

GSK Investigational Site, Richmond

27100

GSK Investigational Site, Pavia

27705

GSK Investigational Site, Durham

28007

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28047

GSK Investigational Site, Madrid

32209

GSK Investigational Site, Jacksonville

33613

GSK Investigational Site, Tampa

35128

GSK Investigational Site, Padua

35233

GSK Investigational Site, Birmingham

41013

GSK Investigational Site, Seville

41150

GSK Investigational Site, Modena

44106

GSK Investigational Site, Cleveland

46009

GSK Investigational Site, Valencia

55100

GSK Investigational Site, Florence

60614

GSK Investigational Site, Chicago

70112

GSK Investigational Site, New Orleans

75235

GSK Investigational Site, Dallas

76104

GSK Investigational Site, Fort Worth

90027

GSK Investigational Site, Los Angeles

02118

GSK Investigational Site, Boston

11794-8111

GSK Investigational Site, Stony Brook

27599-7220

GSK Investigational Site, Chapel Hill

M5G 1X8

GSK Investigational Site, Toronto

H3T 1C5

GSK Investigational Site, Montreal

00165

GSK Investigational Site, Rome

3015 GE

GSK Investigational Site, Rotterdam

1649-035

GSK Investigational Site, Lisbon

021105

GSK Investigational Site, Bucharest

030303

GSK Investigational Site, Bucharest

08003

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08950

GSK Investigational Site, Barcelona

07014

GSK Investigational Site, Palma de Mallorca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY